Brief: Cumberland Pharmaceuticals - Got Notification From FDA Setting PDUFA Action Date
24/01/2019 23:16
Jan 24 (Reuters) - Cumberland Pharmaceuticals Inc CPIX.O :
* CUMBERLAND PHARMA - GOT NOTIFICATION FROM FDA SETTING SEPT
2019
AS PDUFA ACTION DATE FOR APPROVAL DECISION REGARDING NDA FOR
METHOTREXATE PRODUCT LINE
* CUMBERLAND PHARMACEUTICALS - REMITTED PAYMENT OF $1.3
MILLION
TO FDA FOR PDUFA APPLICATION FEE ASSOCIATED WITH METHOTREXATE
PRODUCT LINE NDA
Source text: [https://bit.ly/2S3iFOG]
Further company coverage: CPIX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cumberland Pharmaceuticals
See all newsBrief: Cumberland Pharmaceuticals Announces Assist-Ssc Trial Top-Line Results
Cumberland Pharmaceuticals Q2 loss widens after Apotex transaction
Brief: Cumberland Pharmaceuticals Announces Special Dividend Of $1.50 Per Share
Cumberland Pharmaceuticals Q1 revenue up 5%; to sell FDA‑approved brands to Apotex for $100 mln
NASDAQ RESUMED AT 09:38 AM